LEGN logo

Legend Biotech (LEGN) Company Overview

Profile

Full Name:

Legend Biotech Corporation

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 5, 2020

Indexes:

Not included

Website:

http://www.legendbiotech.com

Description:

Legend Biotech is a biotechnology company focused on developing innovative cell therapies for cancer treatment. They use advanced technology to create personalized therapies that aim to improve patient outcomes. Their goal is to transform cancer care and provide new hope for patients worldwide.

Key Details

Price

$34.97

Market Cap

$6.42 B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$285.14 M(+143.70% YoY)

Annual EPS

-$2.94(-5.00% YoY)

PE Ratio

-

Annual ROE

-51.94%

Annual Debt To Equity

0.22

Beta

0.65

Events Calendar

Earnings

Next earnings date:

Mar 11, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 11, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 21, 25 HC Wainwright & Co.
Buy
Dec 30, 24 Piper Sandler
Overweight
Dec 10, 24 HC Wainwright & Co.
Buy
Dec 9, 24 RBC Capital
Outperform
Dec 9, 24 Cantor Fitzgerald
Overweight
Nov 13, 24 HC Wainwright & Co.
Buy
Oct 29, 24 RBC Capital
Outperform
Oct 16, 24 HC Wainwright & Co.
Buy

Screeners with LEGN included

Growing Shares Outstanding
Mid cap stocks
US stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks
Biotechnology industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$34.97
LEGN price is $34.97

Price All-time High

$77.00
LEGN price is currently -54.58% below its historical high of $77.00

Price Analysts Target

$82.00
LEGN price is currently -57.35% lower than the consensus analysts' forecast

Price Today Change

+2.1%
LEGN price is up +2.1% today

Price YTD Change

+8.77%
LEGN price is up +8.77% since January 1st

Price 3-Year Change

-0.88%
LEGN price is down -0.88% over the past 3 years

Market cap

Market Cap

$6.42 B
LEGN market capitalization is $6.42 billion

Market Cap 3-Year Change

+17.9%
LEGN market capitalization is up +17.9% over the past 3 years

Market Cap All-time High

$13.96 B
LEGN market capitalization is currently -54.06% below its historical high of $13.96 billion

Market Cap Sector Rank

90.12%
LEGN market capitalization is higher than 90.12% of companies in Healthcare sector

Technical

Beta

0.65
LEGN beta is 0.65

200-day SMA

$44.32
LEGN price is currently -21.11% below its 200-day simple moving average

14-day RSI

40.92
LEGN 14-day relative strength index is 40.92

30-day Relative Volume

0.69
LEGN 30-day relative volume is 0.69

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$285.14 M
LEGN annual revenue is $285.14 million

Annual Revenue Analysts Estimate

$615.76 M
LEGN annual revenue is currently -53.69% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+143.7%
LEGN annual revenue is up +143.7% year-on-year

Annual Revenue Sector Rank

68.91%
LEGN annual revenue is higher than 68.91% of companies in Healthcare sector

Profit

Annual Gross Profit

$140.93 M
LEGN annual gross profit is $140.93 million

Annual Gross Margin

49.42%
LEGN annual gross profit margin is 49.42%

Annual Operating Profit

-$439.49 M
LEGN annual operating income is -$439.49 million

Annual Operating Margin

-154.13%
LEGN annual operating profit margin is -154.13%

Annual Net Income

-$518.25 M
LEGN annual net profit is -$518.25 million

Annual Net Margin

-181.75%
LEGN annual net profit margin is -181.75%

EPS

Annual EPS

-$2.94
LEGN annual earnings per share is -$2.94

Annual EPS Analysts Estimate

-$1.40
LEGN annual earnings per share is currently +110.32% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-5%
LEGN annual earnings per share is down -5% year-on-year

Annual EPS Sector Rank

33.33%
LEGN annual earnings per share is higher than 33.33% of companies in Healthcare sector

ROA & ROE

Annual ROA

-32.60%
LEGN annual return on assets is -32.60%

Annual ROE

-51.94%
LEGN annual return on equity is -51.94%

EBIT & EBITDA

Annual EBIT

-$498.32 M
LEGN annual earnings before interest & taxes is -$498.32 million

Annual EBITDA

-$477.87 M
LEGN annual EBITDA is -$477.87 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
LEGN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
LEGN price to earnings ratio is unknown

PB Ratio

PB Ratio

5.75
LEGN price to book ratio is 5.75

PB Ratio Sector Rank

84.98%
LEGN price to book ratio is higher than 84.98% of companies in Healthcare sector

PS Ratio

PS Ratio

12.33
LEGN price to sales ratio is 12.33

PS Ratio Sector Rank

80.13%
LEGN price to sales ratio is higher than 80.13% of companies in Healthcare sector

Enterprise value

Enterprise Value

$6.30 B
LEGN enterprise value is $6.30 billion

Enterprise Value Sector Rank

89.31%
LEGN enterprise value is higher than 89.31% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-20.92
LEGN EV/EBITDA is -20.92

EV/EBITDA Sector Rank

6.09%
LEGN EV/EBITDA is higher than 6.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

6.92
LEGN annual current ratio is 6.92

Annual Quick Ratio

6.83
LEGN annual quick ratio is 6.83

Leverage

Annual Debt To Equity

0.22
LEGN annual debt to equity ratio is 0.22

Annual Interest Coverage Ratio

-22.87
LEGN annual interest coverage ratio is -22.87

Risk & Stability

Piotroski F-Score

3
LEGN piotroski f-score is 3

Altman Z-Score

5.42
LEGN altman z-score is 5.42

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.85 B
LEGN annual total assets is $1.85 billion

Annual Non Current Assets

$350.81 M
LEGN annual long term assets is $350.81 million

Annual Current Assets

$1.50 B
LEGN annual total current assets is $1.50 billion

Annual Cash & Cash Equivalents

$1.28 B
LEGN annual cash & cash equivalents is $1.28 billion

Equity

Annual Book Value

$1.25 B
LEGN annual book value is $1.25 billion

Annual Working Capital

$1.28 B
LEGN annual working capital is $1.28 billion

Liabilities

Annual Total Liabilities

$597.24 M
LEGN annual total liabilities is $597.24 million

Annual Total Long Term Liabilities

$380.82 M
LEGN annual total long term liabilities is $380.82 million

Annual Current Liabilities

$216.42 M
LEGN annual total current liabilities is $216.42 million

Annual Accounts Payable

$19.56 M
LEGN annual accounts payable is $19.56 million

Debt

Annual Total Debt

$328.67 M
LEGN annual total debt is $328.67 million

Annual Total Debt 1-Year Change

+15.51%
LEGN annual total debt is up +15.51% year-on-year

Annual Long Term Debt

$325.50 M
LEGN annual long term debt is $325.50 million

Annual Short Term Debt

$3.17 M
LEGN annual short term debt is $3.17 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$724.63 M
LEGN annual total expenses is $724.63 million

Annual Operating Expenses

$580.41 M
LEGN annual total operating expenses is $580.41 million

Annual Cost Of Goods Sold

$144.21 M
LEGN annual cost of goods sold is $144.21 million

Annual SGA

$200.93 M
LEGN annual SGA is $200.93 million

Annual D&A

$20.45 M
LEGN annual depreciation & amortization is $20.45 million

Annual Interest Expense

$21.79 M
LEGN annual interest expense is $21.79 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$393.28 M
LEGN annual cash flow from operations is -$393.28 million

Annual CFO 1-Year Change

-95.39%
LEGN annual cash flow from operations is down -95.39% year-on-year

Annual CFI

$92.79 M
LEGN annual cash flow from investing activities is $92.79 million

Annual CFI 1-Year Change

+220.36%
LEGN annual cash flow from investing activities is up +220.36% year-on-year

Annual CFF

$791.49 M
LEGN annual cash flow from financing activities is $791.49 million

Annual CFF 1-Year Change

+109.4%
LEGN annual cash flow from financing activities is up +109.4% year-on-year

Free CashFlow

Annual FCF

-$416.00 M
LEGN annual free cash flow is -$416.00 million

Annual FCF 1-Year Change

-86.08%
LEGN annual free cash flow is down -86.08% year-on-year

CAPEX

Annual CAPEX

$22.72 M
LEGN annual capital expenditures is $22.72 million

Annual CAPEX 1-Year Change

+2.01%
LEGN annual capital expenditures is up +2.01% year-on-year

Institutional Ownership

Similar stocks

BBIO logo
BridgeBio Pharma (BBIO)
CORT logo
Corcept Therapeutics Incorporated (CORT)
GKOS logo
Glaukos (GKOS)
AXSM logo
Axsome Therapeutics (AXSM)
TFX logo
Teleflex Incorporated (TFX)
MMSI logo
Merit Medical Systems (MMSI)
BPMC logo
Blueprint Medicines (BPMC)
ALKS logo
Alkermes (ALKS)
Telix Pharmaceuticals Limited (TLX)

FAQ

  • What is the ticker symbol for Legend Biotech?
  • Does Legend Biotech pay dividends?
  • What sector is Legend Biotech in?
  • What industry is Legend Biotech in?
  • What country is Legend Biotech based in?
  • When did Legend Biotech go public?
  • Is Legend Biotech in the S&P 500?
  • Is Legend Biotech in the NASDAQ 100?
  • Is Legend Biotech in the Dow Jones?
  • When was Legend Biotech's last earnings report?
  • When does Legend Biotech report earnings?
  • Should I buy Legend Biotech stock now?

What is the ticker symbol for Legend Biotech?

The ticker symbol for Legend Biotech is NASDAQ:LEGN

Does Legend Biotech pay dividends?

No, Legend Biotech does not pay dividends

What sector is Legend Biotech in?

Legend Biotech is in the Healthcare sector

What industry is Legend Biotech in?

Legend Biotech is in the Biotechnology industry

What country is Legend Biotech based in?

Legend Biotech is headquartered in United States

When did Legend Biotech go public?

Legend Biotech's initial public offering (IPO) was on June 5, 2020

Is Legend Biotech in the S&P 500?

No, Legend Biotech is not included in the S&P 500 index

Is Legend Biotech in the NASDAQ 100?

No, Legend Biotech is not included in the NASDAQ 100 index

Is Legend Biotech in the Dow Jones?

No, Legend Biotech is not included in the Dow Jones index

When was Legend Biotech's last earnings report?

Legend Biotech's most recent earnings report was on Nov 12, 2024

When does Legend Biotech report earnings?

The next expected earnings date for Legend Biotech is Mar 11, 2025

Should I buy Legend Biotech stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions